Search results
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 3 hours agoSales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition from cheaper...
Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: Eli Lilly raised its revenue forecast for the year by $2 billion as sales of its GLP-1...
Pfizer: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 5 hours agoThe results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 56 cents per share. The drugmaker
Alkermes: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 5 hours agoThe results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 59 cents per share. The drugmaker& ...
United Therapeutics: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 6 hours agoThe results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $5.63 per share. The drugmaker
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters· 6 hours ago, opens new tab raised its full-year profit forecast on Wednesday on strong demand for its common...
Drugmaker Indivior to seek shareholder nod on shifting primary listing to US
Reuters via Yahoo Finance· 6 days agoApril 25 (Reuters) - UK-listed drugmaker Indivior Plc said on Thursday it intends to seek shareholder approval next month to facilitate a primary listing in the United States ...
GSK (GSK) Q1 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 5 hours agoGlaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Pfizer profits drop on lower Covid-19 product sales
Digital Journal· 4 hours agoMuch lower sales of Covid-19 vaccine Comirnaty and therapeutic Paxlovid accounted for a 20 percent drop in first-quarter revenues to $14.9 billion...
REUTERS NEWS SCHEDULE AT 10:00 a.m. GMT/ 6:00 a.m. ET
Reuters via Yahoo Finance· 6 hours agoInvestors will closely watch any changes to the drugmaker's 2024 forecast, especially for COVID-19 vaccine and antiviral treatment Paxlovid. Fcus will also be on the performance ...
